Hemen Kapadia of KRChoksey Securities told CNBC-TV18, "In last two years Biocon has gone nowhere. It is totally rangebound. If it is a short-term view also we are in a range between Rs 455 and Rs 495, for the last 18 or 22 trading sessions with no directional bias.""Firstly, you need to keep a stoploss at Rs 472 and if Rs 495 gets taken out with volumes, we would see a smart jump to Rs 510 and maybe to Rs 520. So as of now it is a hold, it doesn’t look bad, it hasn’t done much better either in the recent past or in the past couple of years," he said.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!